Table 2 - uploaded by John Rovers
Content may be subject to copyright.
Semi-Structured Interview Questions Procurement 1. Please tell me about how you decide which drugs to purchase. 2. Please tell me about your drug tendering process.
Source publication
Background
The social determinants of health include the health systems under which people live and utilize health services. One social determinant, for which pharmacists are responsible, is designing drug distribution systems that ensure patients have safe and convenient access to medications. This is critical for settings with poor access to heal...
Context in source publication
Context 1
... com- munity pharmacy in a regional capital city that served as the primary source of drug supply declined to be inter- viewed, but provided brief written answers to the inter- view questions. The interview questions are included in Table 2. The specific questions asked varied according to the responsibilities of each interviewee. ...
Citations
... This is in line with the pharmacist's responsibility for addressing sufficient access to medications, one of the social determinants of health. When pharmacists provide care to a community that is underprivileged, rural, or remote, this duty becomes vital [23]. More than one-third of pharmacists in the current study said that telepharmacy can provide more drug availability and information to patients in remote places, and about half were uncertain. ...
Telepharmacy is a technology-based service that provides promoted services such as counseling, medication administration and compounding, drug therapy monitoring, and prescription review. It is unclear whether hospital pharmacists possess the necessary knowledge, attitudes, and willingness to practice telepharmacy. The current study sought to investigate Saudi Arabian hospital pharmacists’ understanding, attitudes, and level of preparedness for telepharmacy services. A total of 411 pharmacists responded to the survey. Only 43.33% of the respondents agreed that telepharmacy is available in Saudi Arabia and 36.67% of the respondents agreed that patients in rural areas can have more medication access and information via telepharmacy. Only 29.33% of pharmacists agreed that telepharmacy improves patient medication adherence, and about 34.00% of the pharmacists agreed that telepharmacy saves patients money and time by eliminating the need for them to travel to healthcare facilities. This research found that hospital pharmacists were unsure of their level of knowledge, their attitude toward telepharmacy, and their willingness to incorporate it into their future pharmacy practices. To ensure that tomorrow’s pharmacists have the skills they need to provide telepharmacy services, telepharmacy practice models must be incorporated into the educational programs that prepare them.
... Reasons for this were primarily because the role of the pharmacist/pharmacy specifically was not described or if it was, then this role and how it focussed on Aboriginal and/or Torres Strait Islander people was not discussed. Whilst Rovers and Mages 35 (2017) Studies included in review (n = 7) 38 (2010) both provided a practical overview of how to assist Aboriginal patients with medication management but this was not specific to one sector of health care, instead it was relevant to many areas which may include pharmacy. The work of de Dassel et al. 39 (2017) investigated adherence in Indigenous Australians and chronic condition management. ...
Aim
To systematically review the literature to investigate the role of the hospital pharmacist and the services provided for Aboriginal and/or Torres Strait Islander people.
Methods
A systematic literature review was performed following a search from inception to present of MEDLINE, International Pharmaceutical Abstracts (IPA), EMBASE, Scopus and Pubmed, in accordance with PRISMA guidelines. All forms of published literature were included. Aboriginal and/or Torres Strait Islander people and hospital pharmacists/pharmacy department services in Australia were the populations included.
Results
1592 studies were identified. After removal of duplicates and application of inclusion and exclusion criteria, 16 papers underwent full text review, with 7 papers included in the final review. No high‐level evidence articles were found. Joanna Briggs Institute Levels of Evidence for meaningfulness were low. Settings were varied and included rural, remote and urban sites. Five articles were allocated a Donabedian Model level where the structure was described. Two papers described structure and process. None described outcomes. Hospital pharmacy services included development of models for patient care, partnerships and resource sharing in rural and remote areas and ensuring continuity of care.
Conclusion
Systematic review of the literature to determine the role of hospital pharmacy services for Aboriginal and/or Torres Strait Islander people produced limited publications for review. From these, roles identified included: development of models for patient care, partnerships and resource sharing in rural and remote areas and ensuring continuity of care. Future research and publication of work by hospital pharmacists nurturing and developing relationships in partnership with Aboriginal and Torres Strait Islander communities is encouraged.
Pharmaceutical warehouses are among the centers that play a critical role in the delivery of medicines from the producers to the consumers. Especially with the new drugs and vaccines added during the pandemic period to the supply chain, the importance of the regions they are located in has increased critically. Since the selection of pharmaceutical warehouse location is a strategic decision, it should be handled in detail and a comprehensive analysis should be made for the location selection process. Considering all these, in this study, a real-case application by taking the problem of selecting the best location for a pharmaceutical warehouse is carried out for a city that can be seen as critical in drug distribution in Turkey. For this aim, two effective multi-criteria decision-making (MCDM) methodologies, namely Analytic Hierarchy Process (AHP) and Evaluation based on Distance from Average Solution (EDAS), are integrated under spherical fuzzy environment to reflect fuzziness and indeterminacy better in the decision-making process and the pharmaceutical warehouse location selection problem is discussed by the proposed fuzzy integrated methodology for the first time. Finally, the best region is found for the pharmaceutical warehouse and the results are discussed under the determined criteria. A detailed robustness analysis is also conducted to measure the validity, sensibility and effectiveness of the proposed methodology. With this study, it can be claimed that literature has initiated to be revealed for the pharmaceutical warehouse location problem and a guide has been put forward for those who are willing to study this area.
The purpose of this study is to identify a system for tracking the distribution of increasingly abused prescription drugs. The problems identified in the study was the increase of prescribed drugs falling into the category of drugs that are frequently abused and this was as a result of improper systems in place designed to track such drugs alongside normal drug distribution networks. The theories of drug abuse highlight the propensity for the increased rate of drug abuse amongst individuals and why it has become imperative that a system that will track such drugs be developed and must be dynamic to readily update new discoveries falling into the abuse category. The study used the object-oriented design methodology to formulate designs for the system through eliciting information on the subject matter with documents and literature of previous works, empirical investigations and personal interviews. The obtained knowledge was then used in designing the proposed system requirements. Manual tests were carried out in units for each component’s functionality before the system was tested as a single integrated unit. The study concludes with the development of a system that can meet the dynamic requirements for tracking the distribution of drugs that are subject to drug abuse along with the distribution framework.
With improvements in cancer treatment and supportive care, a growing population of survivors of childhood cancer at risk for significant and potentially life-threatening late effects has been identified. To provide a current snapshot of the models of care from countries with varying levels of resources and health care systems, stakeholders in childhood cancer survivorship clinical care and research were identified from 18 countries across five continents. Stakeholders responded to a survey and provided a brief narrative regarding the current state of survivorship care. Findings indicate that among pediatric-age survivors of childhood cancer (allowing for differences in age cutoffs across countries), resources are generally available, and a large proportion of survivors are seen by a physician familiar with late effects in most countries. After survivors transition to adulthood, only a minority are seen by a physician familiar with late effects. Despite the need to improve communication between pediatric oncology and primary care, only a few countries have existing national efforts to educate primary care physicians, although many more reported that educational programs are in development. These data highlight common challenges and potential solutions for the lifelong care of survivors of childhood cancer. Combining risk-based and patient-oriented solutions for this population is likely to benefit both providers and patients.
